Scientists report that they have learned how certain combinations of rearranged genes can promote the progression of a rare ...

During a live event, Pedro C. Barata, MD, MSc, discussed the case of a patient with advanced clear cell renal cell carcinoma ...

"We’ve been asked to step in for Three Doors Down on the upcoming dates of the Creed Tour while Brad focuses on his health ...

Recent therapeutic advances have changed the treatment landscape of metastatic renal cell carcinoma. Unfortunately, the seven agents now available are not based on biomarkers that would indicate ...

Allogene Therapeutics is cutting back to stretch its cash runway into the second half of 2027, laying off 28% of its ...

Gene and cell therapies (GCTs) can target the kidney to treat congenital, acute or chronic diseases affecting this organ.

Background: Thioredoxin reductase (Trx) has been implicated in activation of hypoxia-inducible factor-1α, which is overexpressed in > 85% of renal cell carcinomas (RCCs). We evaluated the safety ...

Matt Bramel began volunteering with the Doolittle Rural Fire Protection District in Phelps County when he was a teenager in 1989. “He started as a young boy, as a junior fireman, and rose through the ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 RAs may help prevent the disease.

Currently, there is limited understanding of the molecular subtypes of fumarate hydratase (FH)-deficient renal cell carcinoma (RCC). Here, the authors employ integrated genomics and ...

Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal ...

The FDA has approved Welireg (belzutifan) for the treatment of patients aged 12 years and older with locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma.